[CLDX] YoY Quarter Result on 31-Dec-2011 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Mar-2012
Financial Year
2011
Quarter
31-Dec-2011 [#Q4]
Profit Trend
QoQ- -8.15%
YoY- -156.18%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 1,477 620 3,647 2,434 37,721 4,733 2,988 -11.07%
PBT -31,821 -22,062 -16,807 -12,294 23,046 -13,020 -6,386 30.67%
Tax -229 -137 -94 268 1,449 -159 -1,444 -26.41%
NP -31,821 -22,062 -16,807 -12,732 22,661 -12,943 -7,453 27.35%
Tax Rate - - - - -6.29% - - -
Total Cost 33,298 22,682 20,454 15,166 15,060 17,676 10,442 21.31%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -2,154.43 -3,558.39 -460.84 -523.09 60.08 -273.46 -249.41 43.21%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -5.33 -3.71 -4.03 -3.81 10.61 -6.13 -7.08 -4.61%
EPS Diluted -5.33 -3.71 -4.03 -3.81 10.61 -6.13 -7.07 -4.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.